FDA blesses nonprofit-backed Chagas drug, thwarting ex-Shkreli biotech’s bid for rival launch
admin 30th August 2017 Uncategorised 0Marking a dramatic step for partners aiming to affordably treat Chagas patients, the FDA approved their antiparasitic treatment benznidazole Tuesday. But the approval is an equally dramatic setback for Humanigen—and that drugmaker may have former CEO Martin Shkreli to thank for its loss.
More: FDA blesses nonprofit-backed Chagas drug, thwarting ex-Shkreli biotech’s bid for rival launch
Source: fierce